Open an account

QT Imaging Holdings

QTI · NASDAQ

$2.33+$0.00 (+0.00%)TodayMarket closed ·
Prev close $2.33

About QTI

QT Imaging Holdings, Inc. is a medical device company, which engages in the research, development, and commercialization of body imaging systems using low energy sound. The company is headquartered in Novato, California and currently employs 32 full-time employees. The company went IPO on 2021-09-24. The firm's products include QTI Breast Acoustic CT Scanner and QTviewer Software. QTI’s Breast Acoustic CT scanner with QTViewer viewer software is the only three-dimensional (3D) imaging device to receive United States Food and Drug Administration (FDA) clearance for use as a transmission and reflection ultrasonic imaging system of a patients breast. QTviewer is its proprietary image viewing and analysis platform, purpose-built to interpret the rich, quantitative datasets generated by the QTI Breast Acoustic CT™ scanner. The QTviewer allows users to rotate, zoom, and cross-navigate entire breast volumes. Whether isolating lesions or exploring architectural distortion, radiologists can interact with the data dynamically to gain an understanding of tissue structure and lesion morphology.

Employees
32
Headquarters
Novato, California
Listed
Sep 24, 2021
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
gigcapitalglobal.com

QTI key statistics

Market cap
34.10M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
32.69K
Volume
14.43K
Open price
$2.31
High today
$2.73
Low today
$2.31
52 Week high
$8.50
52 Week low
$2.00

QT Imaging Holdings (QTI) at a glance

As of Oct 20, 2026, QT Imaging Holdings (QTI) shares are priced at $2.33, giving the company a market cap of 34.10M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $2.31 and $2.73. The current price is 0.9% above the day's low and 14.7% below its high.

Volume so far is 14.43K shares, below the average of 32.69K shares a day.

Over the past year QT Imaging Holdings has ranged from $2.00 to $8.50, and now sits 5% of the way up that range.

The average analyst price target is $11.83, 407.8% above the current price, from 1 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 1 analyst rating say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 3 analystsAvg $11.83
Low
$10.10
Now
$2.33
High
$13.86

QTI news

  • Press releaseBusiness Wire

    QT Imaging’s Breast Acoustic CT™ Scanner Now Available Through National Group Purchasing Agreement with Premier

  • Press releaseBusiness Wire

    QT Imaging Announces CPT® Category III Code for 3D Breast Acoustic Imaging Now Effective

  • Press releaseBusiness Wire

    QT Imaging to Ring the Nasdaq Closing Bell on October 2 in Recognition of Breast Cancer Awareness Month

  • Press releaseBusiness Wire

    QT Imaging to be Honored at Premier’s Annual Supplier Innovation Celebration

  • Press releaseBusiness Wire

    QT Imaging Appoints Imaging Industry Veteran Dr. Mark Winkler as Chief Medical Officer

  • Press releaseBusiness Wire

    QT Imaging to Participate in the iAccess Alpha Virtual Best Ideas Fall Investment Conference

  • Press releaseBusiness Wire

    QT Imaging Issues Mid-Year 2026 CEO Letter to Shareholders

  • Press releaseBusiness Wire

    QT Imaging Delivers Strong Second Quarter Growth While Building the Foundation for Commercial Scale

Similar companies

Companies in the same industry as QT Imaging Holdings

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.